Quality of life in long-term survivors of metastatic breast cancer

Clinical Breast Cancer

Volumn 12, Issue 2, 2012, Pages 119-126

  Meisel, Jane L ^a   Domchek, Susan M ^b   Vonderheide, Robert H ^b   Giobbie Hurder, Anita ^c   Lin, Nancy U ^c   Winer, Eric P ^c   Partridge, Ann H ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Advanced breast cancer; Metastatic breast cancer; Quality of life; Survivorship

Indexed keywords

ADULT; ANXIETY; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DEPRESSION; EMOTIONAL STRESS; FEMALE; HUMAN; LONG TERM SURVIVAL; MENTAL STRESS; METASTASIS; QUALITY OF LIFE;

EID: 84858969324     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2012.01.010     Document Type: Article

References (41)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics. CA Cancer J Clin 2010; 60:277-300.
2. American Cancer Society. Breast Cancer Facts and Figures 2009-2010, Table 2. Available at: http://www.cancer.org/acs/groups/content/nho/documents/ document/f861009final90809pdf.pdf. Accessed: March 23, 2011.
3. Stewart BW, Paul Kleihues P. World Cancer Report. Lyon, France: International Agency Research on Cancer; 2003.
4. Peto R, Boreham J, Clarke M, et al. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 2000; 355:1822. (Pubitemid 30265099)
5. Giordano SH, Buzdar AU, Smith TL, et al. Is breast cancer survival improving? Cancer 2004; 100:44-52.
6. Chia SK, Speers CH, D'yachkova Y, et al. The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer 2007; 110:973-9. (Pubitemid 47312861)
7. Horner MJ, Ries LAG, Krapcho M, et al, eds. SEER cancer statistics review, 1975-2006. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975-2006/browse-csr.php?section=4&page= sect-04-table.12.html. Accessed: April 2, 2011.
8. Chung CT, Carlson RW. Goals and objectives in the management of metastatic breast cancer. Oncologist 2003; 8:514-20. (Pubitemid 37467366)
9. Winer EP. Quality-of-life research in patients with breast cancer. Cancer 1994; 74(suppl):410-5. (Pubitemid 24187657)
10. Coates A, Gebski V, Bishop JF, et al. Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. N Engl J Med 1987; 317:1490-5. (Pubitemid 17160543)
11. Van Holten-Verzantvoort ATM, Zwinderman AH, Aaronson NK, et al. The effect of supportive pamidronate on aspects of quality of life of patients with advanced breast cancer. Eur J Cancer 1991; 27:544-9.
12. Fraser SC, Dobbs HJ, Ebbs SR, et al. Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life. Br J Cancer 1993; 67:402-6. (Pubitemid 23049571)
13. Brown JE, Coleman RE. Assessment of the effects of breast cancer on bone and the response to therapy. Breast 2002; 11:375-85. (Pubitemid 35469494)
14. Modi S, Panageas KS, Duck ET, et al. Prospective exploratory analysis of the association between tumor response, quality of life, and expenditures among patients receiving paclitaxel monotherapy for refractory metastatic breast cancer. Clin Oncol 2002; 20:3665-73. (Pubitemid 34983227)
15. Kaklamani VG, Gradishar WJ. Role of capecitabine (Xeloda) in breast cancer. Expert Rev Anticancer Ther 2003; 2:137-44. (Pubitemid 36503391)
16. Karamouzis MV, Ioannidis G, Rigatos G. Quality of life in metastatic breast cancer patients under chemotherapy or supportive care: a single-institution comparative study. Eur J Cancer Care 2007; 16:433-8.
17. Schwartzberg LS, Cobb P, Parker MS, et al. Patient and practice impact of capecitabine compared to taxanes in first/second-line chemotherapy for metastatic breast cancer. Support Care Cancer 2009 [e-pub ahead of print].
18. Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 2008; 27.
19. American Society of Clinical Oncology. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. 1996; 14:671-9.
20. Dow KH, Ferrell BR, Leigh S, et al. An evaluation of the quality of life among long-term survivors of breast cancer. Breast Cancer Res Treat 1996; 39:261-73. (Pubitemid 26278941)
21. Turner J, Kelly B, Swanson C, et al. Psychosocial impact of newly diagnosed advanced breast cancer. Psychooncology 2005; 14:396-407. (Pubitemid 40674417)
22. Northouse LL, Mood D, Kershaw T, et al. Quality of life of women with recurrent breast cancer and their families. J Clin Oncol 2002; 20:4050-64.
23. Bull AA, Meyerowitz BE, Hart S, et al. Quality of life in women with recurrent breast cancer. Breast Cancer Res Treat 1999; 54:47-57. (Pubitemid 29209917)
24. Mayer M. Lessons learned from the metastatic breast cancer community. Semin Oncol Nurs 2010; 26:195-202.
25. Oh S, Heflin L, Meyerowitz BE, et al. Quality of life of breast cancer survivors after a recurrence: a follow-up study. Breast Cancer Res Treat 2004; 87:45-57. (Pubitemid 39237782)
26. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67:361-70. (Pubitemid 13098606)
27. Moorey S, Greer S, Watson M, et al. The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry 1991; 158:255-9.
28. Smith AB, Selby PJ, Velikova G, et al. Factor analysis of the Hospital Anxiety and Depression Scale from a large cancer population. Psychol Psychother 2002; 75:165-76. (Pubitemid 35404156)
29. Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med 1979; 41:209-18. (Pubitemid 9219271)
30. Brady MJ, Cella DF, Mo F, et al. Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. J Clin Oncol 1997; 15:974-86. (Pubitemid 27106280)
31. Broadhead WE, Gehlbach SH, de Gruy FV, et al. The Duke-UNC functional social support questionnaire. Measurement of social support in family medicine patients. Med Care 1988; 26:709-23.
32. Burstein HJ, Gelber S, Guadagnoli E, et al. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999; 340:1733-9. (Pubitemid 29252602)
33. Spiegel D, Bloom JR, Kraemer HC, et al. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989; II:888-91.
34. Goodwin PJ, Leszcz M, Ennis M, et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 2001; 345:1719-26.
35. Spiegel D, Butler LD, Giese-Davis J, et al. Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial. Cancer 2007; 110:1130-8. (Pubitemid 47312880)
36. Ramachandra P, Booth S, Pieters T, et al. A brief self-administered psychological intervention to improve well-being in patients with cancer: results from a feasibility study. Psychooncology 2009; 18:1323-6.
37. Edelman, Bell DR, Kidman AD. A group cognitive behaviour therapy programme with metastatic breast cancer patients. Psychooncology 1999;8:295-305.
38. Kissane DW, Grabsch B, Clarke DM, et al. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psychooncology 2007; 16:277-86. (Pubitemid 46681097)
39. Wyatt G, Sikorskii A, Wills CE, et al. Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer. Nurs Res 2010; 59:58-66.
40. Moadel AB, Shah C, Wylie-Rosett J, et al. Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of life. J Clin Oncol 2007; 25:4387-95. (Pubitemid 350013844)
41. MBCAdvocacy Working Group. Metastatic breast cancer patients: addressing their unmet needs. Community Oncol 2008;5:645-50.